Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog
May 1, 2018, 00:00
10.1016/j.jval.2018.04.488
https://www.valueinhealthjournal.com/article/S1098-3015(18)30788-5/fulltext
Title :
Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30788-5&doi=10.1016/j.jval.2018.04.488
First page :
Section Title :
Open access? :
No
Section Order :
1291